Rubius_Logo.jpg
Rubius Therapeutics Announces 2020 Objectives and Provides Operational Update at the 38th Annual J.P. Morgan Healthcare Conference
January 13, 2020 08:00 ET | Rubius Therapeutics
RTX-240 Investigational New Drug Application for Cancer on File with U.S. Food and Drug Administration Rubius Manufacturing Facility Operational Nine Months Ahead of Schedule and Ready to Supply...
LHC Group
LHC Group to Present at 38th Annual J.P. Morgan Healthcare Conference
January 09, 2020 07:00 ET | LHC Group
LAFAYETTE, La., Jan. 09, 2020 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced today that the Company is presenting at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco...
Rubius_Logo.jpg
Rubius Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
January 02, 2020 16:05 ET | Rubius Therapeutics
CAMBRIDGE, Mass., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an...
AptinyxLogo_FullColor_RGB.jpg
Aptinyx to Present at 38th Annual J.P. Morgan Healthcare Conference
December 12, 2019 07:07 ET | Aptinyx Inc.
EVANSTON, Ill., Dec. 12, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and...
Logo TIGO MIC Blue.png
Millicom files standard form for notification of major holdings
December 11, 2019 12:11 ET | Millicom International Cellular S.A.
Millicom files standard form for notification of major holdings Luxembourg, December 11, 2019 – Millicom International Cellular SA (“Millicom”) announced today the CSSF regulatory filing of the...
Candel Clear Logo (name only).png
Candel Therapeutics Completes $28.7 Million Series B Financing
January 04, 2019 14:33 ET | Candel Therapeutics
Proceeds to Accelerate Enrollment of Phase 3 Localized Prostate Cancer Clinical Trial and to Advance Late Stage High-Grade Glioma Clinical Program Candel to Expand Clinical Trials in Other...
LHC Group
LHC Group to Present at 37th Annual J.P. Morgan Healthcare Conference
January 03, 2019 06:30 ET | LHC Group
LAFAYETTE, La., Jan. 03, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced today that the Company is presenting at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco...
BLOKTechnologies_Logo_Full_FullColour@2x.png
BLOK Technologies Provides Update on Greenstream Networks’ Cannabis Industry Technology
October 17, 2018 09:24 ET | BLOK Technologies Inc.
VANCOUVER, British Columbia, Oct. 17, 2018 (GLOBE NEWSWIRE) -- BLOK Technologies Inc. ("BLOK Tech" or the "Company") (CSE: BLK) (OTC: BLPFF) (FRANKFURT: 2AD) is pleased to provide an update on the...
greystone.png
Jennifer Cherney Joins Greystone as a Managing Director in Seattle
October 15, 2018 09:00 ET | Greystone
NEW YORK, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Greystone, a leading commercial real estate lending, investment and advisory company, has hired Jennifer Cherney as a Managing Director as part of its...
shiloh industries logo.jpg
Shiloh Industries to Participate in the 2018 J.P. Morgan Auto Conference
August 01, 2018 13:41 ET | Shiloh Industries, Inc.
VALLEY CITY, Ohio, Aug. 01, 2018 (GLOBE NEWSWIRE) -- An industry leader in lightweighting, Shiloh Industries, Inc. (NASDAQ:SHLO) today announced that Ramzi Hermiz, president and chief executive...